IBDEI134 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19141,2)
 ;;=^338239
 ;;^UTILITY(U,$J,358.3,19142,0)
 ;;=438.14^^105^1227^10
 ;;^UTILITY(U,$J,358.3,19142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19142,1,4,0)
 ;;=4^438.14
 ;;^UTILITY(U,$J,358.3,19142,1,5,0)
 ;;=5^CVA w/Fluency (late effect)
 ;;^UTILITY(U,$J,358.3,19142,2)
 ;;=^338240
 ;;^UTILITY(U,$J,358.3,19143,0)
 ;;=438.30^^105^1227^20
 ;;^UTILITY(U,$J,358.3,19143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19143,1,4,0)
 ;;=4^438.30
 ;;^UTILITY(U,$J,358.3,19143,1,5,0)
 ;;=5^CVA w/Monoplegia Upper Arm (late effect)
 ;;^UTILITY(U,$J,358.3,19143,2)
 ;;=^317913
 ;;^UTILITY(U,$J,358.3,19144,0)
 ;;=438.31^^105^1227^16
 ;;^UTILITY(U,$J,358.3,19144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19144,1,4,0)
 ;;=4^438.31
 ;;^UTILITY(U,$J,358.3,19144,1,5,0)
 ;;=5^CVA w/Monoplegia Dominant Upper Arm
 ;;^UTILITY(U,$J,358.3,19144,2)
 ;;=^317914
 ;;^UTILITY(U,$J,358.3,19145,0)
 ;;=438.32^^105^1227^19
 ;;^UTILITY(U,$J,358.3,19145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19145,1,4,0)
 ;;=4^438.32
 ;;^UTILITY(U,$J,358.3,19145,1,5,0)
 ;;=5^CVA w/Monoplegia Nondominant Upper Arm
 ;;^UTILITY(U,$J,358.3,19145,2)
 ;;=^317915
 ;;^UTILITY(U,$J,358.3,19146,0)
 ;;=438.40^^105^1227^17
 ;;^UTILITY(U,$J,358.3,19146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19146,1,4,0)
 ;;=4^438.40
 ;;^UTILITY(U,$J,358.3,19146,1,5,0)
 ;;=5^CVA w/Monoplegia Lower Limb,Unspec
 ;;^UTILITY(U,$J,358.3,19146,2)
 ;;=^317916
 ;;^UTILITY(U,$J,358.3,19147,0)
 ;;=438.41^^105^1227^15
 ;;^UTILITY(U,$J,358.3,19147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19147,1,4,0)
 ;;=4^438.41
 ;;^UTILITY(U,$J,358.3,19147,1,5,0)
 ;;=5^CVA w/Monoplegia Dominant Lower Limb
 ;;^UTILITY(U,$J,358.3,19147,2)
 ;;=^317917
 ;;^UTILITY(U,$J,358.3,19148,0)
 ;;=438.42^^105^1227^18
 ;;^UTILITY(U,$J,358.3,19148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19148,1,4,0)
 ;;=4^438.42
 ;;^UTILITY(U,$J,358.3,19148,1,5,0)
 ;;=5^CVA w/Monoplegia Nondominant Lower Limb
 ;;^UTILITY(U,$J,358.3,19148,2)
 ;;=^317918
 ;;^UTILITY(U,$J,358.3,19149,0)
 ;;=438.50^^105^1227^24
 ;;^UTILITY(U,$J,358.3,19149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19149,1,4,0)
 ;;=4^438.50
 ;;^UTILITY(U,$J,358.3,19149,1,5,0)
 ;;=5^CVA w/Oth Paralysis,Unspec
 ;;^UTILITY(U,$J,358.3,19149,2)
 ;;=^317919
 ;;^UTILITY(U,$J,358.3,19150,0)
 ;;=438.51^^105^1227^21
 ;;^UTILITY(U,$J,358.3,19150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19150,1,4,0)
 ;;=4^438.51
 ;;^UTILITY(U,$J,358.3,19150,1,5,0)
 ;;=5^CVA w/Oth Paralysis Dominant Side
 ;;^UTILITY(U,$J,358.3,19150,2)
 ;;=^317920
 ;;^UTILITY(U,$J,358.3,19151,0)
 ;;=438.52^^105^1227^22
 ;;^UTILITY(U,$J,358.3,19151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19151,1,4,0)
 ;;=4^438.52
 ;;^UTILITY(U,$J,358.3,19151,1,5,0)
 ;;=5^CVA w/Oth Paralysis Nondominant Side
 ;;^UTILITY(U,$J,358.3,19151,2)
 ;;=^317921
 ;;^UTILITY(U,$J,358.3,19152,0)
 ;;=438.53^^105^1227^23
 ;;^UTILITY(U,$J,358.3,19152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19152,1,4,0)
 ;;=4^438.53
 ;;^UTILITY(U,$J,358.3,19152,1,5,0)
 ;;=5^CVA w/Oth Paralysis,Bilateral
 ;;^UTILITY(U,$J,358.3,19152,2)
 ;;=^321176
 ;;^UTILITY(U,$J,358.3,19153,0)
 ;;=438.81^^105^1227^4
 ;;^UTILITY(U,$J,358.3,19153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19153,1,4,0)
 ;;=4^438.81
 ;;^UTILITY(U,$J,358.3,19153,1,5,0)
 ;;=5^CVA w/Apraxi NEC
 ;;^UTILITY(U,$J,358.3,19153,2)
 ;;=^317922
 ;;^UTILITY(U,$J,358.3,19154,0)
 ;;=438.83^^105^1227^9
 ;;^UTILITY(U,$J,358.3,19154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19154,1,4,0)
 ;;=4^438.83
 ;;^UTILITY(U,$J,358.3,19154,1,5,0)
 ;;=5^CVA w/Facial Weakness
 ;;
 ;;$END ROU IBDEI134
